I. Park

Identification of a novel TGFBR2 gene mutation in a Korean patient with Loeys–Dietz aortic aneurysm syndrome; no mutation in TGFBR2 gene in 30 patients with classic Marfan's syndrome

C. Ki, B. K. Park, H. Yoo, 2005, Clinical genetics.

D-alanine:D-alanine ligase: phosphonate and phosphinate intermediates with wild type and the Y216F mutant.

C. Walsh, C. Fan, J. Knox, 1997, Biochemistry.

Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story.

C. Walsh, S. Fisher, Z Wu, 1996, Chemistry & biology.

Gain of D-alanyl-D-lactate or D-lactyl-D-alanine synthetase activities in three active-site mutants of the Escherichia coli D-alanyl-D-alanine ligase B.

C. H. Lin, C. Walsh, I. Park, 1996, Biochemistry.

Glycopeptide Antibiotic Resistance Genes in Glycopeptide-Producing Organisms

G. Wright, C. G. Marshall, I. A. Lessard, 1998, Antimicrobial Agents and Chemotherapy.

Detection of maternal uniparental disomy at the two imprinted genes on chromosome 7, GRB10 and PEG1/MEST, in a Silver–Russell syndrome patient using methylation‐specific PCR assays

S.S. Kim, Y. Kim, I. Park, 2005, Clinical genetics.

Active-site mutants of the VanC2 D-alanyl-D-serine ligase, characteristic of one vancomycin-resistant bacterial phenotype, revert towards wild-type D-alanyl-D-alanine ligases.

C. Walsh, I. Park, V. Healy, 1998, Chemistry & biology.

Determinants for differential effects on D-Ala-D-lactate vs D-Ala-D-Ala formation by the VanA ligase from vancomycin-resistant enterococci.

C. Walsh, I. A. Lessard, I. Park, 1999, Biochemistry.

Bacterial resistance to vancomycin: overproduction, purification, and characterization of VanC2 from Enterococcus casseliflavus as a D-Ala-D-Ser ligase.

C. H. Lin, C. Walsh, I. Park, 1997, Proceedings of the National Academy of Sciences of the United States of America.